Clinical Trials Browser

Phase 2 × UNKNOWN × Breast Neoplasms × Clear all

NCT05566457 2022-10-04

HGWD Improve the Paclitaxel-related Neurotoxicity in Patients With BC

Phase 2 Unknown

Breast Neoplasms

NCT03535961 2020-12-02

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT04002284 2020-07-29

Anlotinib in Metastatic HER2 Negative Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT04194684 2019-12-11

Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT04033172 2019-07-25

Pyrotinib

Phase 2 Unknown

Breast Neoplasms

NCT02768415 2019-06-19

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03933982 2019-05-29

Pyrotinib

Phase 2 Unknown

Brain Neoplasms, Breast Neoplasms

NCT03923166 2019-04-22

Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03923179 2019-04-22

Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT03735082 2018-11-08

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT02646735 2017-01-02

FRIEND

Phase 2 Unknown

Breast Neoplasms

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT01939054 2015-06-04

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms

NCT02460744 2015-06-02

2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT01928680 2015-02-23

Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer

Phase 2 Unknown

33 enrolled 5 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02313051 2014-12-09

MIRACLE

Phase 2 Unknown

Breast Neoplasms

NCT02041338 2014-11-25

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT01492543 2013-03-15

Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT01492556 2013-03-15

Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT01431053 2013-03-13

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

Phase 2 Unknown

Breast Neoplasms